InvestorsHub Logo

tfris

11/15/18 11:34 AM

#8643 RE: ShareRunner #8641

I sent them email yesterday and haven’t heard back. My issue is what is the value of a wound care approval vs hemostat and would/could hospitals use it off label when they see product in action?
Very odd to me price hasn’t gone up a little in anticipation of approval so maybe I’ve been wrong all along. Will still hold though, AC5 has some value IMO, either through ARTH or selling company for couple hundred mil after approval.

moneymaker290

11/15/18 1:11 PM

#8645 RE: ShareRunner #8641

I have sent many emails and have NEVER got a response..

I have everything in this...